Drawing for PL PRO-LAB DIAGNOSTICS

USPTO serial 90661817

PL PRO-LAB DIAGNOSTICS

Reviewed by CopyMark Law Group

Reg. 6693050Status 700Registered
Filing date
Status date
Registration date
Apr 5, 2022
Examiner
SHANOSKI, JOANNA MARIE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with PL PRO-LAB DIAGNOSTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Benjamin Sley

Benjamin Sley PRO-LAB DIAGNOSTICS - IN HOUSE ATTORNEY21 CYPRESS BLVD., STE 1155ROUND ROCK, TX 78665UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Reagents for research purposes; Reagents for scientific and research use; Reagents for scientific or medical research use; Reagents for use in scientific apparatus for chemical or biological analysis; Diagnostic reagents for clinical or medical laboratory use; Diagnostic reagents for scientific or research use; Diagnostic reagents for scientific use; Diagnostic preparations for clinical or medical laboratory useACTIVEAug 29, 1994
005Reagents for medical use; Chemical reagents for medical or veterinary purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, COVID-19; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents for the analysis of body fluidsACTIVEAug 29, 1994
009Laboratory chemical reactors; Laboratory equipment and supplies, namely, test tubes; Laboratory equipment, namely, microscope slides; Laboratory equipment, namely, plastic, rubber and elastomer closures, seals and stoppers for laboratory bottles; Laboratory equipment, namely, spectroscopes; Laboratory filters; Laboratory glassware; Laboratory pipettes; Laboratory storage tubes; Beakers; Crucibles for laboratory use; Flasks for laboratory use; Hand-operated laboratory tools for manipulating laboratory samples; Pipette racks for laboratory use; Pipette tips for laboratory useACTIVEAug 29, 1994

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (R.PR): Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.

DateCodeEventWhat it means
Apr 5, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 18, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 18, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 29, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 13, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 13, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Dec 13, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 13, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 13, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 11, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 10, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 10, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 7, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 7, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 7, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 6, 2021DOCKASSIGNED TO EXAMINER—
Jul 29, 2021MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jul 28, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 24, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance